Pharma giant Gilead's price for coronavirus drug draws criticism
The US maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $US2340 for a typical treatment course.
Full Article
Pharma giant Gilead's price for coronavirus drug draws criticism
Brisbane Times
0 shares
1 views
You might like
Related news coverage
US stocks trade mixed as investors weigh reopening hopes against virus spread
Business Insider
· *US stocks traded mixed on Monday as investors continued to bet on economic reopenings despite soaring coronavirus case..
-
NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Biocept, Globex Mining Enterprises, Q BioMed, ImagineAR UPDATE …
Proactive Investors
-
Gilead slaps multi-thousand-dollar price tag on coronavirus treatment remdesivir
Proactive Investors
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors
Advertisement
More coverage
People are paying as much as $10,000 for an unlicensed remdesivir variant for their cats, in a thriving black market linked to Facebook groups
Business Insider
· A variant of remdesivir, one of the most promising treatments for COVID-19, has for more than a year been sold as a treatment..